Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures
about
Proteomic Upregulation of Fatty Acid Synthase and Fatty Acid Binding Protein 5 and Identification of Cancer- and Race-Specific Pathway Associations in Human Prostate Cancer Tissues.Compensatory pathways induced by MEK inhibition are effective drug targets for combination therapy against castration-resistant prostate cancerEmerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in OncologyA novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery.Clinical targeting of mutated and wild-type protein tyrosine kinases in cancer.Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activationProteomics in prostate cancer biomarker discovery.RNAi-based validation of antibodies for reverse phase protein arrays.MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays.A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers.Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer.FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer.Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survivalApplication of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.The diverse heterogeneity of molecular alterations in prostate cancer identified through next-generation sequencingIndividualized therapy for metastatic colorectal cancer.Discovering cancer biomarkers from clinical samples by protein microarrays.Identification of Transcription Factor YY1 as a Regulator of a Prostate Cancer-Specific Pathway Using Proteomic Analysis.MAP Kinases and Prostate Cancer.Identification of candidate genes that may contribute to the metastasis of prostate cancer by bioinformatics analysis.Profiling signalling pathways in formalin-fixed and paraffin-embedded breast cancer tissues reveals cross-talk between EGFR, HER2, HER3 and uPAR.Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing.Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
P2860
Q30357469-F32D7F28-7B17-4019-9444-85728C7FD613Q30425261-E089623F-CAEC-4AE0-9731-BC5DC53D2A18Q30438965-AB0D4D4E-AD4A-4374-9060-599F6D6E029CQ30504566-282AE20B-82A4-4895-9300-0D023D896D60Q33567004-27B3D564-6BE2-4240-8986-1897C2D79C74Q33602552-6394BAB8-FC5A-43C5-A139-951C74A179CFQ33901255-66CFBE40-95E9-4573-955D-72EDDAA7CAA9Q34096086-A3A681F4-227F-4171-8710-6AF313308ED5Q34500104-38DBFC95-44E2-4CC2-A80B-6EDF62EEB90BQ34574636-058A25ED-7C4F-49BA-9CD0-29C602D7B0FCQ35049524-76E32526-4F1E-474E-B661-BB9D01043961Q36298492-883C5931-3B8B-4F8D-B53F-A61A22C492F5Q37379842-CA249A62-E712-4913-9BB2-0BCC8FE13D77Q37699442-7D2E9A71-FE62-487A-8A27-4FDC22EFEAB3Q37790704-6A51D779-D765-469A-9A46-F96F65DF9C60Q38090427-ADE208DC-F72C-42B3-B176-90A76DCA013FQ38092886-190867AF-D2CD-4EF6-904F-2D6D004A2976Q38293886-2DA1A5FB-6833-42CD-8517-337EE7C5199AQ38399742-3660D012-9F25-41EE-B105-FE65CBD7A710Q38791344-16F2E661-D0C3-4ACC-B5F4-5C31A4EBEBE4Q49330777-D264A46E-350E-43E4-B622-4FFE21706C33Q54605761-6FC9630E-3502-49BF-A3E2-CC564AF9A8D2Q54689509-5008A0AD-BF4D-4F94-8171-6142835F325FQ55361958-E97C85D5-FA3A-4B90-86F3-8B5772CBD806
P2860
Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Pathway biomarker profiling of ...... atic and prognostic signatures
@ast
Pathway biomarker profiling of ...... atic and prognostic signatures
@en
type
label
Pathway biomarker profiling of ...... atic and prognostic signatures
@ast
Pathway biomarker profiling of ...... atic and prognostic signatures
@en
prefLabel
Pathway biomarker profiling of ...... atic and prognostic signatures
@ast
Pathway biomarker profiling of ...... atic and prognostic signatures
@en
P2093
P2860
P356
P1476
Pathway biomarker profiling of ...... atic and prognostic signatures
@en
P2093
Arul Chinnaiyan
Emanuel F Petricoin
James L Mohler
Jianghong Deng
Julia D Wulfkuhle
Lance A Liotta
Peter A Pinto
Robert L Grubb
W Marston Linehan
P2860
P304
P356
10.1021/PR8009337
P50
P577
2009-06-01T00:00:00Z